nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—SULT1A1—prostate cancer	0.122	0.356	CbGaD
Tamoxifen—ESR2—prostate cancer	0.0342	0.1	CbGaD
Tamoxifen—ESRRA—Estradiol—prostate cancer	0.0336	0.0809	CbGbCtD
Tamoxifen—CYP1B1—prostate cancer	0.0312	0.0914	CbGaD
Tamoxifen—DHCR7—Epirubicin—prostate cancer	0.0281	0.0678	CbGbCtD
Tamoxifen—ESR2—Estramustine—prostate cancer	0.0281	0.0676	CbGbCtD
Tamoxifen—CYP3A5—prostate cancer	0.0249	0.0728	CbGaD
Tamoxifen—CYP2A6—prostate cancer	0.0241	0.0704	CbGaD
Tamoxifen—CYP19A1—prostate cancer	0.0229	0.0671	CbGaD
Tamoxifen—ESR1—prostate cancer	0.0211	0.0617	CbGaD
Tamoxifen—ESR2—Estrone—prostate cancer	0.0181	0.0436	CbGbCtD
Tamoxifen—CYP2E1—prostate cancer	0.0171	0.05	CbGaD
Tamoxifen—CYP2C19—prostate cancer	0.0169	0.0495	CbGaD
Tamoxifen—CYP1A1—prostate cancer	0.0169	0.0493	CbGaD
Tamoxifen—ESR2—Ethinyl Estradiol—prostate cancer	0.0161	0.0388	CbGbCtD
Tamoxifen—DHCR7—Doxorubicin—prostate cancer	0.0149	0.036	CbGbCtD
Tamoxifen—ESR1—Estramustine—prostate cancer	0.0144	0.0346	CbGbCtD
Tamoxifen—CYP1B1—Flutamide—prostate cancer	0.0128	0.0309	CbGbCtD
Tamoxifen—CES1—Capecitabine—prostate cancer	0.0122	0.0294	CbGbCtD
Tamoxifen—ESR2—Conjugated Estrogens—prostate cancer	0.0118	0.0285	CbGbCtD
Tamoxifen—CYP3A4—prostate cancer	0.0108	0.0315	CbGaD
Tamoxifen—ESR2—Estradiol—prostate cancer	0.0104	0.025	CbGbCtD
Tamoxifen—CYP1B1—Estrone—prostate cancer	0.00926	0.0223	CbGbCtD
Tamoxifen—ESR1—Estrone—prostate cancer	0.00926	0.0223	CbGbCtD
Tamoxifen—ESR1—Ethinyl Estradiol—prostate cancer	0.00825	0.0199	CbGbCtD
Tamoxifen—ABCB11—Ethinyl Estradiol—prostate cancer	0.00825	0.0199	CbGbCtD
Tamoxifen—ESR1—Conjugated Estrogens—prostate cancer	0.00606	0.0146	CbGbCtD
Tamoxifen—CYP1A1—Flutamide—prostate cancer	0.00562	0.0135	CbGbCtD
Tamoxifen—CYP1B1—Mitoxantrone—prostate cancer	0.00551	0.0133	CbGbCtD
Tamoxifen—CYP1B1—Estradiol—prostate cancer	0.00532	0.0128	CbGbCtD
Tamoxifen—ESR1—Estradiol—prostate cancer	0.00532	0.0128	CbGbCtD
Tamoxifen—ABCG2—Cabazitaxel—prostate cancer	0.0045	0.0109	CbGbCtD
Tamoxifen—ABCG2—Estrone—prostate cancer	0.0044	0.0106	CbGbCtD
Tamoxifen—ABCC2—Ethinyl Estradiol—prostate cancer	0.00434	0.0105	CbGbCtD
Tamoxifen—CYP1A1—Estrone—prostate cancer	0.00406	0.00979	CbGbCtD
Tamoxifen—CYP2C8—Nilutamide—prostate cancer	0.00391	0.00943	CbGbCtD
Tamoxifen—CYP3A5—Flutamide—prostate cancer	0.00337	0.00813	CbGbCtD
Tamoxifen—CYP2C19—Bicalutamide—prostate cancer	0.00328	0.00791	CbGbCtD
Tamoxifen—CYP2C19—Nilutamide—prostate cancer	0.00328	0.00791	CbGbCtD
Tamoxifen—CYP2C8—Abiraterone—prostate cancer	0.00324	0.00781	CbGbCtD
Tamoxifen—ABCC2—Conjugated Estrogens—prostate cancer	0.00319	0.00767	CbGbCtD
Tamoxifen—CYP1B1—Docetaxel—prostate cancer	0.00318	0.00766	CbGbCtD
Tamoxifen—CYP2E1—Estrone—prostate cancer	0.00314	0.00756	CbGbCtD
Tamoxifen—CYP2B6—Estrone—prostate cancer	0.0031	0.00746	CbGbCtD
Tamoxifen—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00302	0.00728	CbGbCtD
Tamoxifen—ABCG2—Conjugated Estrogens—prostate cancer	0.00288	0.00694	CbGbCtD
Tamoxifen—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00276	0.00665	CbGbCtD
Tamoxifen—CYP2C9—Bicalutamide—prostate cancer	0.00273	0.00658	CbGbCtD
Tamoxifen—CYP2C9—Nilutamide—prostate cancer	0.00273	0.00658	CbGbCtD
Tamoxifen—CYP2C19—Flutamide—prostate cancer	0.00272	0.00656	CbGbCtD
Tamoxifen—ABCG2—Mitoxantrone—prostate cancer	0.00262	0.00631	CbGbCtD
Tamoxifen—ABCG2—Estradiol—prostate cancer	0.00253	0.00609	CbGbCtD
Tamoxifen—CYP1A2—Flutamide—prostate cancer	0.00251	0.00605	CbGbCtD
Tamoxifen—CYP2D6—Bicalutamide—prostate cancer	0.0025	0.00602	CbGbCtD
Tamoxifen—CYP3A5—Cabazitaxel—prostate cancer	0.0025	0.00601	CbGbCtD
Tamoxifen—ABCB1—Estramustine—prostate cancer	0.00246	0.00593	CbGbCtD
Tamoxifen—CYP3A5—Estrone—prostate cancer	0.00244	0.00588	CbGbCtD
Tamoxifen—CYP2C8—Cabazitaxel—prostate cancer	0.0024	0.00578	CbGbCtD
Tamoxifen—ABCB11—Doxorubicin—prostate cancer	0.00237	0.00571	CbGbCtD
Tamoxifen—CYP1B1—Doxorubicin—prostate cancer	0.00237	0.00571	CbGbCtD
Tamoxifen—CYP1A1—Estradiol—prostate cancer	0.00233	0.00562	CbGbCtD
Tamoxifen—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00209	0.00504	CbGbCtD
Tamoxifen—CYP2D6—Abiraterone—prostate cancer	0.00207	0.00498	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00187	0.0045	CbGbCtD
Tamoxifen—CYP3A7—Estradiol—prostate cancer	0.00187	0.0045	CbGbCtD
Tamoxifen—CYP2E1—Mitoxantrone—prostate cancer	0.00187	0.0045	CbGbCtD
Tamoxifen—ABCC2—Etoposide—prostate cancer	0.00183	0.0044	CbGbCtD
Tamoxifen—FMO3—urine—prostate cancer	0.00183	0.0507	CbGeAlD
Tamoxifen—CYP1A2—Estrone—prostate cancer	0.00182	0.00437	CbGbCtD
Tamoxifen—ABCC2—Docetaxel—prostate cancer	0.00167	0.00403	CbGbCtD
Tamoxifen—ABCG2—Etoposide—prostate cancer	0.00165	0.00398	CbGbCtD
Tamoxifen—CYP2C9—Estrone—prostate cancer	0.00164	0.00394	CbGbCtD
Tamoxifen—ABCB1—Cabazitaxel—prostate cancer	0.00162	0.00391	CbGbCtD
Tamoxifen—CYP3A4—Bicalutamide—prostate cancer	0.00159	0.00382	CbGbCtD
Tamoxifen—ABCB1—Estrone—prostate cancer	0.00159	0.00382	CbGbCtD
Tamoxifen—ABCG2—Docetaxel—prostate cancer	0.00151	0.00364	CbGbCtD
Tamoxifen—CYP3A4—Estramustine—prostate cancer	0.00148	0.00356	CbGbCtD
Tamoxifen—ABCB1—Ethinyl Estradiol—prostate cancer	0.00141	0.00341	CbGbCtD
Tamoxifen—CYP19A1—semen—prostate cancer	0.00141	0.0391	CbGeAlD
Tamoxifen—CYP3A5—Estradiol—prostate cancer	0.0014	0.00338	CbGbCtD
Tamoxifen—CYP2C8—Estradiol—prostate cancer	0.00135	0.00325	CbGbCtD
Tamoxifen—EBPL—prostate gland—prostate cancer	0.00134	0.0372	CbGeAlD
Tamoxifen—CYP3A4—Abiraterone—prostate cancer	0.00132	0.00317	CbGbCtD
Tamoxifen—CYP3A4—Flutamide—prostate cancer	0.00132	0.00317	CbGbCtD
Tamoxifen—ABCC2—Doxorubicin—prostate cancer	0.00125	0.003	CbGbCtD
Tamoxifen—CYP2C9—Capecitabine—prostate cancer	0.00124	0.00299	CbGbCtD
Tamoxifen—CYP1A2—Conjugated Estrogens—prostate cancer	0.00119	0.00286	CbGbCtD
Tamoxifen—CYP2E1—Etoposide—prostate cancer	0.00118	0.00284	CbGbCtD
Tamoxifen—CYP2C19—Estradiol—prostate cancer	0.00113	0.00272	CbGbCtD
Tamoxifen—ABCG2—Doxorubicin—prostate cancer	0.00113	0.00271	CbGbCtD
Tamoxifen—CYP3A7—Docetaxel—prostate cancer	0.00112	0.00269	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00112	0.00269	CbGbCtD
Tamoxifen—SULT1A1—prostate gland—prostate cancer	0.00107	0.0296	CbGeAlD
Tamoxifen—CYP1A2—Estradiol—prostate cancer	0.00104	0.00251	CbGbCtD
Tamoxifen—ABCB1—Conjugated Estrogens—prostate cancer	0.00104	0.0025	CbGbCtD
Tamoxifen—EBPL—epithelium—prostate cancer	0.000986	0.0274	CbGeAlD
Tamoxifen—CYP3A4—Cabazitaxel—prostate cancer	0.000973	0.00234	CbGbCtD
Tamoxifen—CYP2C19—Prednisone—prostate cancer	0.000972	0.00234	CbGbCtD
Tamoxifen—CYP3A4—Estrone—prostate cancer	0.000951	0.00229	CbGbCtD
Tamoxifen—ABCB1—Mitoxantrone—prostate cancer	0.000944	0.00227	CbGbCtD
Tamoxifen—CYP2C9—Estradiol—prostate cancer	0.000939	0.00226	CbGbCtD
Tamoxifen—CYP3A5—Etoposide—prostate cancer	0.000915	0.0022	CbGbCtD
Tamoxifen—ABCB1—Estradiol—prostate cancer	0.000912	0.0022	CbGbCtD
Tamoxifen—SULT1A1—seminal vesicle—prostate cancer	0.000901	0.025	CbGeAlD
Tamoxifen—CYP2C8—Etoposide—prostate cancer	0.000879	0.00212	CbGbCtD
Tamoxifen—CYP3A4—Ethinyl Estradiol—prostate cancer	0.000848	0.00204	CbGbCtD
Tamoxifen—CYP3A5—Docetaxel—prostate cancer	0.000837	0.00202	CbGbCtD
Tamoxifen—CYP2C19—urine—prostate cancer	0.000807	0.0224	CbGeAlD
Tamoxifen—CYP2B6—Doxorubicin—prostate cancer	0.000792	0.00191	CbGbCtD
Tamoxifen—ABCB1—Prednisone—prostate cancer	0.000784	0.00189	CbGbCtD
Tamoxifen—DHCR7—prostate gland—prostate cancer	0.000758	0.021	CbGeAlD
Tamoxifen—FMO1—prostate gland—prostate cancer	0.000758	0.021	CbGeAlD
Tamoxifen—ESRRA—prostate gland—prostate cancer	0.000746	0.0207	CbGeAlD
Tamoxifen—SULT1A1—renal system—prostate cancer	0.000726	0.0202	CbGeAlD
Tamoxifen—CYP1A2—Etoposide—prostate cancer	0.000681	0.00164	CbGbCtD
Tamoxifen—CYP1A2—urine—prostate cancer	0.000659	0.0183	CbGeAlD
Tamoxifen—FMO3—prostate gland—prostate cancer	0.000655	0.0182	CbGeAlD
Tamoxifen—DHCR7—seminal vesicle—prostate cancer	0.000641	0.0178	CbGeAlD
Tamoxifen—UGT1A4—renal system—prostate cancer	0.000634	0.0176	CbGeAlD
Tamoxifen—ESRRA—seminal vesicle—prostate cancer	0.000631	0.0175	CbGeAlD
Tamoxifen—CYP2C9—urine—prostate cancer	0.000625	0.0174	CbGeAlD
Tamoxifen—CYP3A4—Conjugated Estrogens—prostate cancer	0.000622	0.0015	CbGbCtD
Tamoxifen—ABCB1—Etoposide—prostate cancer	0.000595	0.00143	CbGbCtD
Tamoxifen—CYP2E1—urine—prostate cancer	0.000593	0.0165	CbGeAlD
Tamoxifen—EBPL—testis—prostate cancer	0.000591	0.0164	CbGeAlD
Tamoxifen—CYP3A4—Mitoxantrone—prostate cancer	0.000566	0.00136	CbGbCtD
Tamoxifen—CYP3A4—Estradiol—prostate cancer	0.000546	0.00132	CbGbCtD
Tamoxifen—ABCB1—Docetaxel—prostate cancer	0.000545	0.00131	CbGbCtD
Tamoxifen—CES1—prostate gland—prostate cancer	0.000517	0.0144	CbGeAlD
Tamoxifen—FMO1—renal system—prostate cancer	0.000517	0.0143	CbGeAlD
Tamoxifen—ESRRA—renal system—prostate cancer	0.000509	0.0141	CbGeAlD
Tamoxifen—FMO1—urethra—prostate cancer	0.000508	0.0141	CbGeAlD
Tamoxifen—DHCR7—urethra—prostate cancer	0.000508	0.0141	CbGeAlD
Tamoxifen—ESRRA—urethra—prostate cancer	0.0005	0.0139	CbGeAlD
Tamoxifen—CYP3A4—urine—prostate cancer	0.000477	0.0132	CbGeAlD
Tamoxifen—CYP3A4—Prednisone—prostate cancer	0.00047	0.00113	CbGbCtD
Tamoxifen—SULT1A1—testis—prostate cancer	0.00047	0.013	CbGeAlD
Tamoxifen—CYP2D6—urine—prostate cancer	0.000469	0.013	CbGeAlD
Tamoxifen—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000451	1	CbGdCrCtD
Tamoxifen—CYP2A6—prostate gland—prostate cancer	0.00045	0.0125	CbGeAlD
Tamoxifen—ESR2—prostate gland—prostate cancer	0.000448	0.0124	CbGeAlD
Tamoxifen—EBPL—lymph node—prostate cancer	0.000428	0.0119	CbGeAlD
Tamoxifen—ABCB1—Doxorubicin—prostate cancer	0.000406	0.000978	CbGbCtD
Tamoxifen—DHCR7—bone marrow—prostate cancer	0.000391	0.0108	CbGeAlD
Tamoxifen—ESRRA—bone marrow—prostate cancer	0.000385	0.0107	CbGeAlD
Tamoxifen—CYP2D6—Doxorubicin—prostate cancer	0.000383	0.000922	CbGbCtD
Tamoxifen—CYP2A6—seminal vesicle—prostate cancer	0.000381	0.0106	CbGeAlD
Tamoxifen—CYP3A4—Etoposide—prostate cancer	0.000357	0.000859	CbGbCtD
Tamoxifen—CYP19A1—prostate gland—prostate cancer	0.000353	0.0098	CbGeAlD
Tamoxifen—SIGMAR1—prostate gland—prostate cancer	0.000347	0.00963	CbGeAlD
Tamoxifen—SULT1A1—lymph node—prostate cancer	0.00034	0.00945	CbGeAlD
Tamoxifen—ABCC2—prostate gland—prostate cancer	0.000337	0.00935	CbGeAlD
Tamoxifen—DHCR7—testis—prostate cancer	0.000334	0.00927	CbGeAlD
Tamoxifen—CYP1B1—prostate gland—prostate cancer	0.00033	0.00916	CbGeAlD
Tamoxifen—ESR2—epithelium—prostate cancer	0.000329	0.00914	CbGeAlD
Tamoxifen—ESRRA—testis—prostate cancer	0.000329	0.00913	CbGeAlD
Tamoxifen—CYP3A4—Docetaxel—prostate cancer	0.000326	0.000786	CbGbCtD
Tamoxifen—Diethylstilbestrol—AOX1—prostate cancer	0.000312	0.13	CrCbGaD
Tamoxifen—ESR1—prostate gland—prostate cancer	0.000307	0.00852	CbGeAlD
Tamoxifen—ESR2—renal system—prostate cancer	0.000305	0.00848	CbGeAlD
Tamoxifen—SIGMAR1—seminal vesicle—prostate cancer	0.000294	0.00815	CbGeAlD
Tamoxifen—ABCB11—testis—prostate cancer	0.000292	0.0081	CbGeAlD
Tamoxifen—FMO3—testis—prostate cancer	0.000289	0.00801	CbGeAlD
Tamoxifen—ABCG2—prostate gland—prostate cancer	0.000246	0.00682	CbGeAlD
Tamoxifen—CYP3A4—Doxorubicin—prostate cancer	0.000243	0.000586	CbGbCtD
Tamoxifen—DHCR7—lymph node—prostate cancer	0.000242	0.00672	CbGeAlD
Tamoxifen—FMO1—lymph node—prostate cancer	0.000242	0.00672	CbGeAlD
Tamoxifen—ESRRA—lymph node—prostate cancer	0.000238	0.00662	CbGeAlD
Tamoxifen—SIGMAR1—urethra—prostate cancer	0.000232	0.00645	CbGeAlD
Tamoxifen—ABCC2—renal system—prostate cancer	0.00023	0.00638	CbGeAlD
Tamoxifen—CYP3A5—prostate gland—prostate cancer	0.000228	0.00633	CbGeAlD
Tamoxifen—CES1—testis—prostate cancer	0.000228	0.00633	CbGeAlD
Tamoxifen—ESR1—epithelium—prostate cancer	0.000225	0.00626	CbGeAlD
Tamoxifen—CYP1B1—renal system—prostate cancer	0.000225	0.00624	CbGeAlD
Tamoxifen—CYP2E1—prostate gland—prostate cancer	0.000213	0.00591	CbGeAlD
Tamoxifen—FMO3—lymph node—prostate cancer	0.000209	0.00581	CbGeAlD
Tamoxifen—ESR1—renal system—prostate cancer	0.000209	0.00581	CbGeAlD
Tamoxifen—ABCG2—seminal vesicle—prostate cancer	0.000208	0.00577	CbGeAlD
Tamoxifen—ESR2—testis—prostate cancer	0.000197	0.00548	CbGeAlD
Tamoxifen—CYP2E1—seminal vesicle—prostate cancer	0.00018	0.005	CbGeAlD
Tamoxifen—SIGMAR1—bone marrow—prostate cancer	0.000179	0.00497	CbGeAlD
Tamoxifen—CYP2C8—renal system—prostate cancer	0.000172	0.00478	CbGeAlD
Tamoxifen—CYP1A1—epithelium—prostate cancer	0.000171	0.00476	CbGeAlD
Tamoxifen—CES1—lymph node—prostate cancer	0.000165	0.00459	CbGeAlD
Tamoxifen—ABCG2—urethra—prostate cancer	0.000165	0.00457	CbGeAlD
Tamoxifen—CYP1A2—renal system—prostate cancer	0.000161	0.00448	CbGeAlD
Tamoxifen—CYP1A1—renal system—prostate cancer	0.000159	0.00441	CbGeAlD
Tamoxifen—CYP1A1—urethra—prostate cancer	0.000156	0.00434	CbGeAlD
Tamoxifen—CYP19A1—testis—prostate cancer	0.000155	0.00432	CbGeAlD
Tamoxifen—CYP3A5—renal system—prostate cancer	0.000155	0.00432	CbGeAlD
Tamoxifen—CYP2B6—renal system—prostate cancer	0.000154	0.00429	CbGeAlD
Tamoxifen—SIGMAR1—testis—prostate cancer	0.000153	0.00424	CbGeAlD
Tamoxifen—Dimetacrine—ACHE—prostate cancer	0.000151	0.063	CrCbGaD
Tamoxifen—ABCC2—testis—prostate cancer	0.000148	0.00412	CbGeAlD
Tamoxifen—CYP1B1—testis—prostate cancer	0.000145	0.00404	CbGeAlD
Tamoxifen—CYP2E1—renal system—prostate cancer	0.000145	0.00403	CbGeAlD
Tamoxifen—ESR2—lymph node—prostate cancer	0.000143	0.00397	CbGeAlD
Tamoxifen—CYP2E1—urethra—prostate cancer	0.000142	0.00395	CbGeAlD
Tamoxifen—Diethylstilbestrol—COMT—prostate cancer	0.000136	0.0565	CrCbGaD
Tamoxifen—ESR1—testis—prostate cancer	0.000135	0.00375	CbGeAlD
Tamoxifen—ABCG2—bone marrow—prostate cancer	0.000127	0.00352	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR2—prostate cancer	0.000127	0.0527	CrCbGaD
Tamoxifen—ABCB1—prostate gland—prostate cancer	0.000121	0.00336	CbGeAlD
Tamoxifen—CYP3A4—renal system—prostate cancer	0.000117	0.00324	CbGeAlD
Tamoxifen—CYP2D6—renal system—prostate cancer	0.000115	0.00319	CbGeAlD
Tamoxifen—CYP19A1—lymph node—prostate cancer	0.000113	0.00313	CbGeAlD
Tamoxifen—CYP2C8—testis—prostate cancer	0.000111	0.00309	CbGeAlD
Tamoxifen—SIGMAR1—lymph node—prostate cancer	0.000111	0.00308	CbGeAlD
Tamoxifen—ABCG2—testis—prostate cancer	0.000108	0.00301	CbGeAlD
Tamoxifen—ABCC2—lymph node—prostate cancer	0.000108	0.00299	CbGeAlD
Tamoxifen—CYP1B1—lymph node—prostate cancer	0.000105	0.00293	CbGeAlD
Tamoxifen—ABCB1—seminal vesicle—prostate cancer	0.000102	0.00285	CbGeAlD
Tamoxifen—CYP2B6—testis—prostate cancer	9.99e-05	0.00277	CbGeAlD
Tamoxifen—ESR1—lymph node—prostate cancer	9.8e-05	0.00272	CbGeAlD
Tamoxifen—CYP2E1—testis—prostate cancer	9.37e-05	0.0026	CbGeAlD
Tamoxifen—ABCB1—epithelium—prostate cancer	8.9e-05	0.00247	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP2A6—prostate cancer	8.9e-05	0.0371	CrCbGaD
Tamoxifen—Diethylstilbestrol—CYP19A1—prostate cancer	8.47e-05	0.0353	CrCbGaD
Tamoxifen—ABCB1—renal system—prostate cancer	8.26e-05	0.00229	CbGeAlD
Tamoxifen—ABCB1—urethra—prostate cancer	8.11e-05	0.00225	CbGeAlD
Tamoxifen—ABCG2—lymph node—prostate cancer	7.85e-05	0.00218	CbGeAlD
Tamoxifen—Diethylstilbestrol—ESR1—prostate cancer	7.79e-05	0.0325	CrCbGaD
Tamoxifen—Bedaquiline—CYP3A4—prostate cancer	7.72e-05	0.0322	CrCbGaD
Tamoxifen—Ospemifene—ESR1—prostate cancer	7.58e-05	0.0316	CrCbGaD
Tamoxifen—CYP1A1—lymph node—prostate cancer	7.45e-05	0.00207	CbGeAlD
Tamoxifen—CYP2D6—testis—prostate cancer	7.42e-05	0.00206	CbGeAlD
Tamoxifen—Diethylstilbestrol—CYP2E1—prostate cancer	6.32e-05	0.0263	CrCbGaD
Tamoxifen—ABCB1—bone marrow—prostate cancer	6.24e-05	0.00173	CbGeAlD
Tamoxifen—Toremifene—ESR1—prostate cancer	6.18e-05	0.0258	CrCbGaD
Tamoxifen—Phenoxybenzamine—SLC22A3—prostate cancer	6.16e-05	0.0257	CrCbGaD
Tamoxifen—Clomifene—CYP2A6—prostate cancer	6.1e-05	0.0254	CrCbGaD
Tamoxifen—Ospemifene—CYP2C19—prostate cancer	6.09e-05	0.0254	CrCbGaD
Tamoxifen—Clomifene—CYP19A1—prostate cancer	5.81e-05	0.0242	CrCbGaD
Tamoxifen—Clomifene—ESR1—prostate cancer	5.34e-05	0.0223	CrCbGaD
Tamoxifen—ABCB1—testis—prostate cancer	5.34e-05	0.00148	CbGeAlD
Tamoxifen—Toremifene—CYP1A1—prostate cancer	4.94e-05	0.0206	CrCbGaD
Tamoxifen—Levomethadyl Acetate—CYP3A5—prostate cancer	4.92e-05	0.0205	CrCbGaD
Tamoxifen—Diphenhydramine—CYP2C18—prostate cancer	4.54e-05	0.0189	CrCbGaD
Tamoxifen—Levomethadyl Acetate—CYP19A1—prostate cancer	4.54e-05	0.0189	CrCbGaD
Tamoxifen—Phenoxybenzamine—SLC22A1—prostate cancer	4.42e-05	0.0184	CrCbGaD
Tamoxifen—Methadone—CYP2C18—prostate cancer	4.38e-05	0.0183	CrCbGaD
Tamoxifen—Clomifene—CYP2E1—prostate cancer	4.33e-05	0.018	CrCbGaD
Tamoxifen—Clomifene—CYP1A1—prostate cancer	4.27e-05	0.0178	CrCbGaD
Tamoxifen—Diethylstilbestrol—CYP3A4—prostate cancer	3.98e-05	0.0166	CrCbGaD
Tamoxifen—Ospemifene—CYP3A4—prostate cancer	3.87e-05	0.0161	CrCbGaD
Tamoxifen—ABCB1—lymph node—prostate cancer	3.87e-05	0.00107	CbGeAlD
Tamoxifen—Diphenhydramine—SLC22A1—prostate cancer	3.7e-05	0.0154	CrCbGaD
Tamoxifen—Toremifene—CYP3A4—prostate cancer	3.15e-05	0.0131	CrCbGaD
Tamoxifen—Methadone—CYP3A5—prostate cancer	2.89e-05	0.012	CrCbGaD
Tamoxifen—Phenoxybenzamine—ADRB2—prostate cancer	2.82e-05	0.0117	CrCbGaD
Tamoxifen—Clomifene—CYP3A4—prostate cancer	2.73e-05	0.0114	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP3A4—prostate cancer	2.73e-05	0.0114	CrCbGaD
Tamoxifen—Methadone—CYP19A1—prostate cancer	2.66e-05	0.0111	CrCbGaD
Tamoxifen—Levomethadyl Acetate—CYP3A4—prostate cancer	2.13e-05	0.00888	CrCbGaD
Tamoxifen—Diphenhydramine—CYP2C19—prostate cancer	2.03e-05	0.00848	CrCbGaD
Tamoxifen—Methadone—CYP2C19—prostate cancer	1.96e-05	0.00818	CrCbGaD
Tamoxifen—Orphenadrine—CYP2E1—prostate cancer	1.94e-05	0.0081	CrCbGaD
Tamoxifen—Dextropropoxyphene—CYP3A4—prostate cancer	1.84e-05	0.00767	CrCbGaD
Tamoxifen—Promazine—CYP2C19—prostate cancer	1.76e-05	0.00731	CrCbGaD
Tamoxifen—Loperamide—CYP3A4—prostate cancer	1.75e-05	0.00731	CrCbGaD
Tamoxifen—Hypertension—Docetaxel—prostate cancer	1.72e-05	0.000155	CcSEcCtD
Tamoxifen—Erythema—Prednisone—prostate cancer	1.72e-05	0.000155	CcSEcCtD
Tamoxifen—Bronchitis—Doxorubicin—prostate cancer	1.72e-05	0.000155	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Epirubicin—prostate cancer	1.71e-05	0.000154	CcSEcCtD
Tamoxifen—Decreased appetite—Etoposide—prostate cancer	1.71e-05	0.000153	CcSEcCtD
Tamoxifen—Arthralgia—Docetaxel—prostate cancer	1.7e-05	0.000153	CcSEcCtD
Tamoxifen—Myalgia—Docetaxel—prostate cancer	1.7e-05	0.000153	CcSEcCtD
Tamoxifen—Chest pain—Docetaxel—prostate cancer	1.7e-05	0.000153	CcSEcCtD
Tamoxifen—Pancytopenia—Doxorubicin—prostate cancer	1.7e-05	0.000153	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Etoposide—prostate cancer	1.69e-05	0.000152	CcSEcCtD
Tamoxifen—Asthenia—Mitoxantrone—prostate cancer	1.69e-05	0.000152	CcSEcCtD
Tamoxifen—Fatigue—Etoposide—prostate cancer	1.69e-05	0.000152	CcSEcCtD
Tamoxifen—Cough—Capecitabine—prostate cancer	1.69e-05	0.000152	CcSEcCtD
Tamoxifen—Constipation—Etoposide—prostate cancer	1.68e-05	0.000151	CcSEcCtD
Tamoxifen—Pain—Etoposide—prostate cancer	1.68e-05	0.000151	CcSEcCtD
Tamoxifen—Urinary tract infection—Epirubicin—prostate cancer	1.68e-05	0.000151	CcSEcCtD
Tamoxifen—Dizziness—Estradiol—prostate cancer	1.67e-05	0.00015	CcSEcCtD
Tamoxifen—Neutropenia—Doxorubicin—prostate cancer	1.67e-05	0.00015	CcSEcCtD
Tamoxifen—Hypertension—Capecitabine—prostate cancer	1.67e-05	0.00015	CcSEcCtD
Tamoxifen—Dry mouth—Docetaxel—prostate cancer	1.66e-05	0.000149	CcSEcCtD
Tamoxifen—Sweating—Epirubicin—prostate cancer	1.65e-05	0.000149	CcSEcCtD
Tamoxifen—Chest pain—Capecitabine—prostate cancer	1.65e-05	0.000148	CcSEcCtD
Tamoxifen—Myalgia—Capecitabine—prostate cancer	1.65e-05	0.000148	CcSEcCtD
Tamoxifen—Arthralgia—Capecitabine—prostate cancer	1.65e-05	0.000148	CcSEcCtD
Tamoxifen—Anxiety—Capecitabine—prostate cancer	1.64e-05	0.000147	CcSEcCtD
Tamoxifen—Oedema—Docetaxel—prostate cancer	1.63e-05	0.000146	CcSEcCtD
Tamoxifen—Weight increased—Doxorubicin—prostate cancer	1.63e-05	0.000146	CcSEcCtD
Tamoxifen—Discomfort—Capecitabine—prostate cancer	1.63e-05	0.000146	CcSEcCtD
Tamoxifen—Infection—Docetaxel—prostate cancer	1.62e-05	0.000146	CcSEcCtD
Tamoxifen—Weight decreased—Doxorubicin—prostate cancer	1.62e-05	0.000145	CcSEcCtD
Tamoxifen—Sinusitis—Epirubicin—prostate cancer	1.62e-05	0.000145	CcSEcCtD
Tamoxifen—Benzphetamine—CYP3A4—prostate cancer	1.61e-05	0.00673	CrCbGaD
Tamoxifen—Diarrhoea—Mitoxantrone—prostate cancer	1.61e-05	0.000145	CcSEcCtD
Tamoxifen—Dry mouth—Capecitabine—prostate cancer	1.61e-05	0.000145	CcSEcCtD
Tamoxifen—Vomiting—Estradiol—prostate cancer	1.61e-05	0.000145	CcSEcCtD
Tamoxifen—Pneumonia—Doxorubicin—prostate cancer	1.6e-05	0.000144	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Etoposide—prostate cancer	1.6e-05	0.000144	CcSEcCtD
Tamoxifen—Thrombocytopenia—Docetaxel—prostate cancer	1.6e-05	0.000143	CcSEcCtD
Tamoxifen—Rash—Estradiol—prostate cancer	1.6e-05	0.000143	CcSEcCtD
Tamoxifen—Dermatitis—Estradiol—prostate cancer	1.59e-05	0.000143	CcSEcCtD
Tamoxifen—Anaemia—Prednisone—prostate cancer	1.59e-05	0.000143	CcSEcCtD
Tamoxifen—Headache—Estradiol—prostate cancer	1.59e-05	0.000142	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	1.58e-05	0.000142	CcSEcCtD
Tamoxifen—Oedema—Capecitabine—prostate cancer	1.58e-05	0.000142	CcSEcCtD
Tamoxifen—Angioedema—Prednisone—prostate cancer	1.57e-05	0.000141	CcSEcCtD
Tamoxifen—Infection—Capecitabine—prostate cancer	1.57e-05	0.000141	CcSEcCtD
Tamoxifen—Urticaria—Etoposide—prostate cancer	1.56e-05	0.00014	CcSEcCtD
Tamoxifen—Haemoglobin—Epirubicin—prostate cancer	1.56e-05	0.00014	CcSEcCtD
Tamoxifen—Anorexia—Docetaxel—prostate cancer	1.55e-05	0.00014	CcSEcCtD
Tamoxifen—Abdominal pain—Etoposide—prostate cancer	1.55e-05	0.000139	CcSEcCtD
Tamoxifen—Urinary tract infection—Doxorubicin—prostate cancer	1.55e-05	0.000139	CcSEcCtD
Tamoxifen—Haemorrhage—Epirubicin—prostate cancer	1.55e-05	0.000139	CcSEcCtD
Tamoxifen—Hepatitis—Epirubicin—prostate cancer	1.55e-05	0.000139	CcSEcCtD
Tamoxifen—Thrombocytopenia—Capecitabine—prostate cancer	1.55e-05	0.000139	CcSEcCtD
Tamoxifen—Phenoxybenzamine—CYP3A4—prostate cancer	1.54e-05	0.00643	CrCbGaD
Tamoxifen—Hypoaesthesia—Epirubicin—prostate cancer	1.54e-05	0.000138	CcSEcCtD
Tamoxifen—Pharyngitis—Epirubicin—prostate cancer	1.54e-05	0.000138	CcSEcCtD
Tamoxifen—Sweating—Doxorubicin—prostate cancer	1.53e-05	0.000137	CcSEcCtD
Tamoxifen—Hyperhidrosis—Capecitabine—prostate cancer	1.53e-05	0.000137	CcSEcCtD
Tamoxifen—Oedema peripheral—Epirubicin—prostate cancer	1.52e-05	0.000137	CcSEcCtD
Tamoxifen—Anorexia—Capecitabine—prostate cancer	1.5e-05	0.000135	CcSEcCtD
Tamoxifen—Nausea—Estradiol—prostate cancer	1.5e-05	0.000135	CcSEcCtD
Tamoxifen—Vomiting—Mitoxantrone—prostate cancer	1.5e-05	0.000135	CcSEcCtD
Tamoxifen—Sinusitis—Doxorubicin—prostate cancer	1.5e-05	0.000134	CcSEcCtD
Tamoxifen—Visual impairment—Epirubicin—prostate cancer	1.49e-05	0.000134	CcSEcCtD
Tamoxifen—Hypertension—Prednisone—prostate cancer	1.49e-05	0.000134	CcSEcCtD
Tamoxifen—Rash—Mitoxantrone—prostate cancer	1.49e-05	0.000134	CcSEcCtD
Tamoxifen—Dermatitis—Mitoxantrone—prostate cancer	1.49e-05	0.000133	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Docetaxel—prostate cancer	1.49e-05	0.000133	CcSEcCtD
Tamoxifen—Headache—Mitoxantrone—prostate cancer	1.48e-05	0.000133	CcSEcCtD
Tamoxifen—Insomnia—Docetaxel—prostate cancer	1.47e-05	0.000132	CcSEcCtD
Tamoxifen—Arthralgia—Prednisone—prostate cancer	1.47e-05	0.000132	CcSEcCtD
Tamoxifen—Myalgia—Prednisone—prostate cancer	1.47e-05	0.000132	CcSEcCtD
Tamoxifen—Paraesthesia—Docetaxel—prostate cancer	1.46e-05	0.000132	CcSEcCtD
Tamoxifen—Erythema multiforme—Epirubicin—prostate cancer	1.46e-05	0.000131	CcSEcCtD
Tamoxifen—Anxiety—Prednisone—prostate cancer	1.46e-05	0.000131	CcSEcCtD
Tamoxifen—Dyspnoea—Docetaxel—prostate cancer	1.45e-05	0.000131	CcSEcCtD
Tamoxifen—Discomfort—Prednisone—prostate cancer	1.45e-05	0.00013	CcSEcCtD
Tamoxifen—Hypersensitivity—Etoposide—prostate cancer	1.45e-05	0.00013	CcSEcCtD
Tamoxifen—Haemoglobin—Doxorubicin—prostate cancer	1.44e-05	0.000129	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Capecitabine—prostate cancer	1.44e-05	0.000129	CcSEcCtD
Tamoxifen—Flushing—Epirubicin—prostate cancer	1.44e-05	0.000129	CcSEcCtD
Tamoxifen—Dyspepsia—Docetaxel—prostate cancer	1.44e-05	0.000129	CcSEcCtD
Tamoxifen—Hepatitis—Doxorubicin—prostate cancer	1.43e-05	0.000129	CcSEcCtD
Tamoxifen—Haemorrhage—Doxorubicin—prostate cancer	1.43e-05	0.000129	CcSEcCtD
Tamoxifen—Insomnia—Capecitabine—prostate cancer	1.43e-05	0.000128	CcSEcCtD
Tamoxifen—Hypoaesthesia—Doxorubicin—prostate cancer	1.43e-05	0.000128	CcSEcCtD
Tamoxifen—Pharyngitis—Doxorubicin—prostate cancer	1.42e-05	0.000128	CcSEcCtD
Tamoxifen—Paraesthesia—Capecitabine—prostate cancer	1.42e-05	0.000127	CcSEcCtD
Tamoxifen—Decreased appetite—Docetaxel—prostate cancer	1.42e-05	0.000127	CcSEcCtD
Tamoxifen—Oedema peripheral—Doxorubicin—prostate cancer	1.41e-05	0.000127	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Docetaxel—prostate cancer	1.41e-05	0.000126	CcSEcCtD
Tamoxifen—Asthenia—Etoposide—prostate cancer	1.41e-05	0.000126	CcSEcCtD
Tamoxifen—Dyspnoea—Capecitabine—prostate cancer	1.41e-05	0.000126	CcSEcCtD
Tamoxifen—Oedema—Prednisone—prostate cancer	1.41e-05	0.000126	CcSEcCtD
Tamoxifen—Fatigue—Docetaxel—prostate cancer	1.41e-05	0.000126	CcSEcCtD
Tamoxifen—Nausea—Mitoxantrone—prostate cancer	1.4e-05	0.000126	CcSEcCtD
Tamoxifen—Infection—Prednisone—prostate cancer	1.4e-05	0.000126	CcSEcCtD
Tamoxifen—Pain—Docetaxel—prostate cancer	1.39e-05	0.000125	CcSEcCtD
Tamoxifen—Constipation—Docetaxel—prostate cancer	1.39e-05	0.000125	CcSEcCtD
Tamoxifen—Dyspepsia—Capecitabine—prostate cancer	1.39e-05	0.000125	CcSEcCtD
Tamoxifen—Pruritus—Etoposide—prostate cancer	1.39e-05	0.000125	CcSEcCtD
Tamoxifen—Arrhythmia—Epirubicin—prostate cancer	1.38e-05	0.000124	CcSEcCtD
Tamoxifen—Visual impairment—Doxorubicin—prostate cancer	1.38e-05	0.000124	CcSEcCtD
Tamoxifen—Decreased appetite—Capecitabine—prostate cancer	1.37e-05	0.000123	CcSEcCtD
Tamoxifen—Alopecia—Epirubicin—prostate cancer	1.37e-05	0.000123	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Capecitabine—prostate cancer	1.36e-05	0.000122	CcSEcCtD
Tamoxifen—Fatigue—Capecitabine—prostate cancer	1.36e-05	0.000122	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisone—prostate cancer	1.36e-05	0.000122	CcSEcCtD
Tamoxifen—Erythema multiforme—Doxorubicin—prostate cancer	1.35e-05	0.000122	CcSEcCtD
Tamoxifen—Constipation—Capecitabine—prostate cancer	1.35e-05	0.000121	CcSEcCtD
Tamoxifen—Pain—Capecitabine—prostate cancer	1.35e-05	0.000121	CcSEcCtD
Tamoxifen—Erythema—Epirubicin—prostate cancer	1.35e-05	0.000121	CcSEcCtD
Tamoxifen—Diarrhoea—Etoposide—prostate cancer	1.34e-05	0.000121	CcSEcCtD
Tamoxifen—Anorexia—Prednisone—prostate cancer	1.34e-05	0.00012	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Docetaxel—prostate cancer	1.33e-05	0.00012	CcSEcCtD
Tamoxifen—Flushing—Doxorubicin—prostate cancer	1.33e-05	0.000119	CcSEcCtD
Tamoxifen—Dysgeusia—Epirubicin—prostate cancer	1.32e-05	0.000119	CcSEcCtD
Tamoxifen—Back pain—Epirubicin—prostate cancer	1.3e-05	0.000117	CcSEcCtD
Tamoxifen—Dizziness—Etoposide—prostate cancer	1.3e-05	0.000117	CcSEcCtD
Tamoxifen—Muscle spasms—Epirubicin—prostate cancer	1.3e-05	0.000116	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Capecitabine—prostate cancer	1.29e-05	0.000116	CcSEcCtD
Tamoxifen—Abdominal pain—Docetaxel—prostate cancer	1.29e-05	0.000116	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Prednisone—prostate cancer	1.28e-05	0.000115	CcSEcCtD
Tamoxifen—Arrhythmia—Doxorubicin—prostate cancer	1.28e-05	0.000115	CcSEcCtD
Tamoxifen—Insomnia—Prednisone—prostate cancer	1.27e-05	0.000114	CcSEcCtD
Tamoxifen—Alopecia—Doxorubicin—prostate cancer	1.27e-05	0.000114	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisone—prostate cancer	1.26e-05	0.000113	CcSEcCtD
Tamoxifen—Urticaria—Capecitabine—prostate cancer	1.25e-05	0.000113	CcSEcCtD
Tamoxifen—Methadone—CYP3A4—prostate cancer	1.25e-05	0.0052	CrCbGaD
Tamoxifen—Abdominal pain—Capecitabine—prostate cancer	1.25e-05	0.000112	CcSEcCtD
Tamoxifen—Vomiting—Etoposide—prostate cancer	1.25e-05	0.000112	CcSEcCtD
Tamoxifen—Erythema—Doxorubicin—prostate cancer	1.25e-05	0.000112	CcSEcCtD
Tamoxifen—Anaemia—Epirubicin—prostate cancer	1.25e-05	0.000112	CcSEcCtD
Tamoxifen—Dyspepsia—Prednisone—prostate cancer	1.24e-05	0.000111	CcSEcCtD
Tamoxifen—Rash—Etoposide—prostate cancer	1.24e-05	0.000111	CcSEcCtD
Tamoxifen—Dermatitis—Etoposide—prostate cancer	1.24e-05	0.000111	CcSEcCtD
Tamoxifen—Headache—Etoposide—prostate cancer	1.23e-05	0.00011	CcSEcCtD
Tamoxifen—Orphenadrine—CYP3A4—prostate cancer	1.22e-05	0.0051	CrCbGaD
Tamoxifen—Decreased appetite—Prednisone—prostate cancer	1.22e-05	0.00011	CcSEcCtD
Tamoxifen—Dysgeusia—Doxorubicin—prostate cancer	1.22e-05	0.00011	CcSEcCtD
Tamoxifen—Fatigue—Prednisone—prostate cancer	1.21e-05	0.000109	CcSEcCtD
Tamoxifen—Leukopenia—Epirubicin—prostate cancer	1.21e-05	0.000108	CcSEcCtD
Tamoxifen—Back pain—Doxorubicin—prostate cancer	1.21e-05	0.000108	CcSEcCtD
Tamoxifen—Constipation—Prednisone—prostate cancer	1.2e-05	0.000108	CcSEcCtD
Tamoxifen—Hypersensitivity—Docetaxel—prostate cancer	1.2e-05	0.000108	CcSEcCtD
Tamoxifen—Muscle spasms—Doxorubicin—prostate cancer	1.2e-05	0.000108	CcSEcCtD
Tamoxifen—Cough—Epirubicin—prostate cancer	1.18e-05	0.000106	CcSEcCtD
Tamoxifen—Asthenia—Docetaxel—prostate cancer	1.17e-05	0.000105	CcSEcCtD
Tamoxifen—Nausea—Etoposide—prostate cancer	1.17e-05	0.000105	CcSEcCtD
Tamoxifen—Hypertension—Epirubicin—prostate cancer	1.16e-05	0.000105	CcSEcCtD
Tamoxifen—Hypersensitivity—Capecitabine—prostate cancer	1.16e-05	0.000104	CcSEcCtD
Tamoxifen—Pruritus—Docetaxel—prostate cancer	1.15e-05	0.000104	CcSEcCtD
Tamoxifen—Anaemia—Doxorubicin—prostate cancer	1.15e-05	0.000104	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Prednisone—prostate cancer	1.15e-05	0.000103	CcSEcCtD
Tamoxifen—Arthralgia—Epirubicin—prostate cancer	1.15e-05	0.000103	CcSEcCtD
Tamoxifen—Chest pain—Epirubicin—prostate cancer	1.15e-05	0.000103	CcSEcCtD
Tamoxifen—Myalgia—Epirubicin—prostate cancer	1.15e-05	0.000103	CcSEcCtD
Tamoxifen—Anxiety—Epirubicin—prostate cancer	1.14e-05	0.000103	CcSEcCtD
Tamoxifen—Discomfort—Epirubicin—prostate cancer	1.13e-05	0.000102	CcSEcCtD
Tamoxifen—Asthenia—Capecitabine—prostate cancer	1.13e-05	0.000102	CcSEcCtD
Tamoxifen—Dry mouth—Epirubicin—prostate cancer	1.12e-05	0.000101	CcSEcCtD
Tamoxifen—Urticaria—Prednisone—prostate cancer	1.12e-05	0.0001	CcSEcCtD
Tamoxifen—Pruritus—Capecitabine—prostate cancer	1.12e-05	0.0001	CcSEcCtD
Tamoxifen—Promazine—CYP3A4—prostate cancer	1.12e-05	0.00465	CrCbGaD
Tamoxifen—Leukopenia—Doxorubicin—prostate cancer	1.12e-05	0.0001	CcSEcCtD
Tamoxifen—Diarrhoea—Docetaxel—prostate cancer	1.12e-05	0.0001	CcSEcCtD
Tamoxifen—Abdominal pain—Prednisone—prostate cancer	1.11e-05	9.99e-05	CcSEcCtD
Tamoxifen—Oedema—Epirubicin—prostate cancer	1.1e-05	9.88e-05	CcSEcCtD
Tamoxifen—Infection—Epirubicin—prostate cancer	1.09e-05	9.82e-05	CcSEcCtD
Tamoxifen—Cough—Doxorubicin—prostate cancer	1.09e-05	9.78e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Capecitabine—prostate cancer	1.08e-05	9.7e-05	CcSEcCtD
Tamoxifen—Dizziness—Docetaxel—prostate cancer	1.08e-05	9.69e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Epirubicin—prostate cancer	1.08e-05	9.67e-05	CcSEcCtD
Tamoxifen—Hypertension—Doxorubicin—prostate cancer	1.08e-05	9.67e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Epirubicin—prostate cancer	1.06e-05	9.55e-05	CcSEcCtD
Tamoxifen—Myalgia—Doxorubicin—prostate cancer	1.06e-05	9.54e-05	CcSEcCtD
Tamoxifen—Arthralgia—Doxorubicin—prostate cancer	1.06e-05	9.54e-05	CcSEcCtD
Tamoxifen—Chest pain—Doxorubicin—prostate cancer	1.06e-05	9.54e-05	CcSEcCtD
Tamoxifen—Anxiety—Doxorubicin—prostate cancer	1.06e-05	9.5e-05	CcSEcCtD
Tamoxifen—Discomfort—Doxorubicin—prostate cancer	1.05e-05	9.42e-05	CcSEcCtD
Tamoxifen—Anorexia—Epirubicin—prostate cancer	1.05e-05	9.42e-05	CcSEcCtD
Tamoxifen—Dizziness—Capecitabine—prostate cancer	1.04e-05	9.38e-05	CcSEcCtD
Tamoxifen—Dry mouth—Doxorubicin—prostate cancer	1.04e-05	9.33e-05	CcSEcCtD
Tamoxifen—Vomiting—Docetaxel—prostate cancer	1.04e-05	9.31e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisone—prostate cancer	1.04e-05	9.31e-05	CcSEcCtD
Tamoxifen—Rash—Docetaxel—prostate cancer	1.03e-05	9.24e-05	CcSEcCtD
Tamoxifen—Dermatitis—Docetaxel—prostate cancer	1.03e-05	9.23e-05	CcSEcCtD
Tamoxifen—Headache—Docetaxel—prostate cancer	1.02e-05	9.18e-05	CcSEcCtD
Tamoxifen—Oedema—Doxorubicin—prostate cancer	1.02e-05	9.14e-05	CcSEcCtD
Tamoxifen—Infection—Doxorubicin—prostate cancer	1.01e-05	9.08e-05	CcSEcCtD
Tamoxifen—Asthenia—Prednisone—prostate cancer	1.01e-05	9.06e-05	CcSEcCtD
Tamoxifen—Vomiting—Capecitabine—prostate cancer	1e-05	9.02e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Epirubicin—prostate cancer	1e-05	9e-05	CcSEcCtD
Tamoxifen—Thrombocytopenia—Doxorubicin—prostate cancer	9.96e-06	8.95e-05	CcSEcCtD
Tamoxifen—Rash—Capecitabine—prostate cancer	9.95e-06	8.94e-05	CcSEcCtD
Tamoxifen—Pruritus—Prednisone—prostate cancer	9.95e-06	8.94e-05	CcSEcCtD
Tamoxifen—Insomnia—Epirubicin—prostate cancer	9.95e-06	8.94e-05	CcSEcCtD
Tamoxifen—Dermatitis—Capecitabine—prostate cancer	9.94e-06	8.93e-05	CcSEcCtD
Tamoxifen—Headache—Capecitabine—prostate cancer	9.89e-06	8.89e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Epirubicin—prostate cancer	9.88e-06	8.87e-05	CcSEcCtD
Tamoxifen—Hyperhidrosis—Doxorubicin—prostate cancer	9.84e-06	8.84e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Epirubicin—prostate cancer	9.81e-06	8.81e-05	CcSEcCtD
Tamoxifen—Anorexia—Doxorubicin—prostate cancer	9.7e-06	8.71e-05	CcSEcCtD
Tamoxifen—Nausea—Docetaxel—prostate cancer	9.69e-06	8.7e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Epirubicin—prostate cancer	9.68e-06	8.7e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Prednisone—prostate cancer	9.62e-06	8.64e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Epirubicin—prostate cancer	9.56e-06	8.59e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Epirubicin—prostate cancer	9.49e-06	8.53e-05	CcSEcCtD
Tamoxifen—Fatigue—Epirubicin—prostate cancer	9.48e-06	8.52e-05	CcSEcCtD
Tamoxifen—Constipation—Epirubicin—prostate cancer	9.4e-06	8.45e-05	CcSEcCtD
Tamoxifen—Pain—Epirubicin—prostate cancer	9.4e-06	8.45e-05	CcSEcCtD
Tamoxifen—Nausea—Capecitabine—prostate cancer	9.38e-06	8.42e-05	CcSEcCtD
Tamoxifen—Dizziness—Prednisone—prostate cancer	9.3e-06	8.35e-05	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.27e-06	8.33e-05	CcSEcCtD
Tamoxifen—Insomnia—Doxorubicin—prostate cancer	9.2e-06	8.27e-05	CcSEcCtD
Tamoxifen—Paraesthesia—Doxorubicin—prostate cancer	9.14e-06	8.21e-05	CcSEcCtD
Tamoxifen—Dyspnoea—Doxorubicin—prostate cancer	9.07e-06	8.15e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Epirubicin—prostate cancer	8.99e-06	8.08e-05	CcSEcCtD
Tamoxifen—Dyspepsia—Doxorubicin—prostate cancer	8.96e-06	8.05e-05	CcSEcCtD
Tamoxifen—Vomiting—Prednisone—prostate cancer	8.94e-06	8.03e-05	CcSEcCtD
Tamoxifen—Rash—Prednisone—prostate cancer	8.87e-06	7.97e-05	CcSEcCtD
Tamoxifen—Dermatitis—Prednisone—prostate cancer	8.86e-06	7.96e-05	CcSEcCtD
Tamoxifen—Decreased appetite—Doxorubicin—prostate cancer	8.85e-06	7.95e-05	CcSEcCtD
Tamoxifen—Headache—Prednisone—prostate cancer	8.81e-06	7.91e-05	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.79e-06	7.89e-05	CcSEcCtD
Tamoxifen—Fatigue—Doxorubicin—prostate cancer	8.77e-06	7.88e-05	CcSEcCtD
Tamoxifen—Urticaria—Epirubicin—prostate cancer	8.74e-06	7.85e-05	CcSEcCtD
Tamoxifen—Pain—Doxorubicin—prostate cancer	8.7e-06	7.82e-05	CcSEcCtD
Tamoxifen—Constipation—Doxorubicin—prostate cancer	8.7e-06	7.82e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Epirubicin—prostate cancer	8.69e-06	7.81e-05	CcSEcCtD
Tamoxifen—Nausea—Prednisone—prostate cancer	8.35e-06	7.5e-05	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Doxorubicin—prostate cancer	8.32e-06	7.48e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Epirubicin—prostate cancer	8.1e-06	7.28e-05	CcSEcCtD
Tamoxifen—Urticaria—Doxorubicin—prostate cancer	8.08e-06	7.26e-05	CcSEcCtD
Tamoxifen—Abdominal pain—Doxorubicin—prostate cancer	8.04e-06	7.23e-05	CcSEcCtD
Tamoxifen—Asthenia—Epirubicin—prostate cancer	7.89e-06	7.09e-05	CcSEcCtD
Tamoxifen—Pruritus—Epirubicin—prostate cancer	7.78e-06	6.99e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Epirubicin—prostate cancer	7.52e-06	6.76e-05	CcSEcCtD
Tamoxifen—Hypersensitivity—Doxorubicin—prostate cancer	7.5e-06	6.74e-05	CcSEcCtD
Tamoxifen—Asthenia—Doxorubicin—prostate cancer	7.3e-06	6.56e-05	CcSEcCtD
Tamoxifen—Dizziness—Epirubicin—prostate cancer	7.27e-06	6.53e-05	CcSEcCtD
Tamoxifen—Pruritus—Doxorubicin—prostate cancer	7.2e-06	6.47e-05	CcSEcCtD
Tamoxifen—Vomiting—Epirubicin—prostate cancer	6.99e-06	6.28e-05	CcSEcCtD
Tamoxifen—Diarrhoea—Doxorubicin—prostate cancer	6.96e-06	6.26e-05	CcSEcCtD
Tamoxifen—Rash—Epirubicin—prostate cancer	6.93e-06	6.23e-05	CcSEcCtD
Tamoxifen—Dermatitis—Epirubicin—prostate cancer	6.93e-06	6.22e-05	CcSEcCtD
Tamoxifen—Headache—Epirubicin—prostate cancer	6.89e-06	6.19e-05	CcSEcCtD
Tamoxifen—Dizziness—Doxorubicin—prostate cancer	6.73e-06	6.05e-05	CcSEcCtD
Tamoxifen—Nausea—Epirubicin—prostate cancer	6.53e-06	5.87e-05	CcSEcCtD
Tamoxifen—Vomiting—Doxorubicin—prostate cancer	6.47e-06	5.81e-05	CcSEcCtD
Tamoxifen—Rash—Doxorubicin—prostate cancer	6.42e-06	5.76e-05	CcSEcCtD
Tamoxifen—Dermatitis—Doxorubicin—prostate cancer	6.41e-06	5.76e-05	CcSEcCtD
Tamoxifen—Headache—Doxorubicin—prostate cancer	6.37e-06	5.73e-05	CcSEcCtD
Tamoxifen—Nausea—Doxorubicin—prostate cancer	6.04e-06	5.43e-05	CcSEcCtD
Tamoxifen—ESR1—Gene Expression—MYC—prostate cancer	4.38e-07	4.71e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.37e-07	4.7e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—EP300—prostate cancer	4.37e-07	4.7e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—prostate cancer	4.36e-07	4.69e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—prostate cancer	4.35e-07	4.68e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—prostate cancer	4.34e-07	4.67e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.34e-07	4.67e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—LPL—prostate cancer	4.33e-07	4.66e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.3e-07	4.63e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—prostate cancer	4.3e-07	4.62e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.29e-07	4.61e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—prostate cancer	4.28e-07	4.61e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—prostate cancer	4.27e-07	4.59e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ACHE—prostate cancer	4.27e-07	4.59e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GGT1—prostate cancer	4.27e-07	4.59e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ERCC2—prostate cancer	4.25e-07	4.57e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.22e-07	4.54e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—prostate cancer	4.22e-07	4.54e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—TYMS—prostate cancer	4.21e-07	4.52e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—EP300—prostate cancer	4.21e-07	4.52e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—INS—prostate cancer	4.21e-07	4.52e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NCOA1—prostate cancer	4.21e-07	4.52e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A1—prostate cancer	4.18e-07	4.5e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—prostate cancer	4.18e-07	4.5e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—JAK2—prostate cancer	4.18e-07	4.49e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—TYMS—prostate cancer	4.17e-07	4.49e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—prostate cancer	4.16e-07	4.47e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ERCC2—prostate cancer	4.15e-07	4.46e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.14e-07	4.46e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAV1—prostate cancer	4.13e-07	4.44e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—prostate cancer	4.12e-07	4.43e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CREBBP—prostate cancer	4.12e-07	4.43e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—INS—prostate cancer	4.12e-07	4.43e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—INS—prostate cancer	4.11e-07	4.42e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.11e-07	4.41e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—prostate cancer	4.1e-07	4.41e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PRKACB—prostate cancer	4.08e-07	4.39e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—LPL—prostate cancer	4.08e-07	4.39e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—prostate cancer	4.08e-07	4.39e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—LPL—prostate cancer	4.05e-07	4.35e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.04e-07	4.35e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CREBBP—prostate cancer	4.04e-07	4.34e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CREBBP—prostate cancer	4.03e-07	4.33e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—prostate cancer	4.02e-07	4.32e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—prostate cancer	4.01e-07	4.32e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—RXRA—prostate cancer	4e-07	4.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—MTHFR—prostate cancer	4e-07	4.3e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—prostate cancer	3.98e-07	4.28e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—prostate cancer	3.97e-07	4.27e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.95e-07	4.24e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.94e-07	4.24e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARA—prostate cancer	3.92e-07	4.22e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ERCC2—prostate cancer	3.91e-07	4.21e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.91e-07	4.2e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—prostate cancer	3.91e-07	4.2e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—MTHFR—prostate cancer	3.9e-07	4.19e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.89e-07	4.18e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—INS—prostate cancer	3.88e-07	4.18e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ERCC2—prostate cancer	3.88e-07	4.17e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—COMT—prostate cancer	3.85e-07	4.14e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOA2—prostate cancer	3.85e-07	4.14e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—prostate cancer	3.83e-07	4.12e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—EP300—prostate cancer	3.83e-07	4.12e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARA—prostate cancer	3.83e-07	4.12e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.83e-07	4.11e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.82e-07	4.11e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—prostate cancer	3.81e-07	4.1e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CREBBP—prostate cancer	3.8e-07	4.09e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—EP300—prostate cancer	3.79e-07	4.08e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ITPR1—prostate cancer	3.77e-07	4.06e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—prostate cancer	3.76e-07	4.05e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1B—prostate cancer	3.72e-07	4.01e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.71e-07	3.99e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—prostate cancer	3.69e-07	3.97e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAV1—prostate cancer	3.69e-07	3.96e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—MTHFR—prostate cancer	3.68e-07	3.95e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.67e-07	3.95e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—prostate cancer	3.65e-07	3.93e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—prostate cancer	3.65e-07	3.92e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—prostate cancer	3.65e-07	3.92e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—MTHFR—prostate cancer	3.64e-07	3.92e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—prostate cancer	3.61e-07	3.89e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—prostate cancer	3.61e-07	3.88e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARA—prostate cancer	3.61e-07	3.88e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—prostate cancer	3.61e-07	3.88e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAV1—prostate cancer	3.6e-07	3.87e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.59e-07	3.86e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARA—prostate cancer	3.58e-07	3.84e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—TYMS—prostate cancer	3.56e-07	3.83e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—INS—prostate cancer	3.56e-07	3.83e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CCND1—prostate cancer	3.55e-07	3.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NQO1—prostate cancer	3.55e-07	3.82e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—prostate cancer	3.52e-07	3.79e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.52e-07	3.79e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CTNNB1—prostate cancer	3.52e-07	3.78e-06	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—prostate cancer	3.5e-07	3.76e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TH—prostate cancer	3.5e-07	3.76e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CREBBP—prostate cancer	3.49e-07	3.75e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—EP300—prostate cancer	3.48e-07	3.74e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—LPL—prostate cancer	3.46e-07	3.72e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—prostate cancer	3.45e-07	3.71e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CDKN1A—prostate cancer	3.44e-07	3.7e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—prostate cancer	3.43e-07	3.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—prostate cancer	3.41e-07	3.66e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—prostate cancer	3.41e-07	3.66e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.4e-07	3.66e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAV1—prostate cancer	3.39e-07	3.65e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—prostate cancer	3.37e-07	3.63e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAV1—prostate cancer	3.36e-07	3.61e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.36e-07	3.61e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.34e-07	3.59e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—prostate cancer	3.34e-07	3.59e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—prostate cancer	3.33e-07	3.58e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ERCC2—prostate cancer	3.31e-07	3.56e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—prostate cancer	3.31e-07	3.56e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—prostate cancer	3.3e-07	3.55e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—prostate cancer	3.3e-07	3.55e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GGT1—prostate cancer	3.29e-07	3.54e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—prostate cancer	3.28e-07	3.52e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EP300—prostate cancer	3.27e-07	3.52e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOA1—prostate cancer	3.25e-07	3.49e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—prostate cancer	3.23e-07	3.48e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.21e-07	3.45e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.2e-07	3.44e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SRC—prostate cancer	3.18e-07	3.42e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—INS—prostate cancer	3.18e-07	3.42e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—prostate cancer	3.14e-07	3.38e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—prostate cancer	3.12e-07	3.36e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—prostate cancer	3.12e-07	3.35e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—MTHFR—prostate cancer	3.11e-07	3.35e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CREBBP—prostate cancer	3.11e-07	3.35e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—prostate cancer	3.11e-07	3.35e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—INS—prostate cancer	3.1e-07	3.34e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—prostate cancer	3.1e-07	3.33e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.09e-07	3.32e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—RXRA—prostate cancer	3.09e-07	3.32e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—prostate cancer	3.07e-07	3.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.06e-07	3.29e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARA—prostate cancer	3.06e-07	3.29e-06	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—prostate cancer	3.04e-07	3.27e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CREBBP—prostate cancer	3.04e-07	3.27e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—COMT—prostate cancer	2.97e-07	3.2e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—prostate cancer	2.96e-07	3.18e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—prostate cancer	2.95e-07	3.17e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—prostate cancer	2.94e-07	3.16e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—INS—prostate cancer	2.92e-07	3.14e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ITPR1—prostate cancer	2.91e-07	3.13e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—INS—prostate cancer	2.9e-07	3.12e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.88e-07	3.1e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—prostate cancer	2.88e-07	3.1e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—prostate cancer	2.88e-07	3.1e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—prostate cancer	2.88e-07	3.09e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAV1—prostate cancer	2.87e-07	3.09e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CREBBP—prostate cancer	2.86e-07	3.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—prostate cancer	2.86e-07	3.07e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—prostate cancer	2.85e-07	3.06e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—prostate cancer	2.84e-07	3.06e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CREBBP—prostate cancer	2.84e-07	3.05e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—prostate cancer	2.83e-07	3.04e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.81e-07	3.02e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—EP300—prostate cancer	2.81e-07	3.02e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—prostate cancer	2.79e-07	3e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—prostate cancer	2.79e-07	3e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—TYMS—prostate cancer	2.75e-07	2.96e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—EP300—prostate cancer	2.75e-07	2.96e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.74e-07	2.95e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—EP300—prostate cancer	2.74e-07	2.95e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—prostate cancer	2.72e-07	2.93e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—prostate cancer	2.72e-07	2.92e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—prostate cancer	2.72e-07	2.92e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.72e-07	2.92e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.69e-07	2.89e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—LPL—prostate cancer	2.67e-07	2.87e-06	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—prostate cancer	2.64e-07	2.84e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—prostate cancer	2.63e-07	2.83e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.62e-07	2.81e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—EP300—prostate cancer	2.59e-07	2.79e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.58e-07	2.77e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.57e-07	2.77e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—prostate cancer	2.57e-07	2.77e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—prostate cancer	2.56e-07	2.76e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ERCC2—prostate cancer	2.56e-07	2.75e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—prostate cancer	2.55e-07	2.74e-06	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—prostate cancer	2.54e-07	2.73e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—prostate cancer	2.54e-07	2.73e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—prostate cancer	2.51e-07	2.7e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—prostate cancer	2.49e-07	2.68e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—prostate cancer	2.49e-07	2.68e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—INS—prostate cancer	2.48e-07	2.66e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CREBBP—prostate cancer	2.43e-07	2.61e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—prostate cancer	2.42e-07	2.6e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—MTHFR—prostate cancer	2.4e-07	2.58e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—EP300—prostate cancer	2.38e-07	2.55e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.37e-07	2.54e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARA—prostate cancer	2.36e-07	2.54e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.35e-07	2.52e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—prostate cancer	2.35e-07	2.52e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—prostate cancer	2.34e-07	2.52e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—prostate cancer	2.32e-07	2.5e-06	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—prostate cancer	2.31e-07	2.49e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.3e-07	2.47e-06	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—prostate cancer	2.29e-07	2.47e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—prostate cancer	2.22e-07	2.39e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAV1—prostate cancer	2.22e-07	2.38e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—prostate cancer	2.17e-07	2.34e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—prostate cancer	2.17e-07	2.33e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—prostate cancer	2.14e-07	2.3e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—EP300—prostate cancer	2.12e-07	2.28e-06	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—prostate cancer	2.1e-07	2.26e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—prostate cancer	2.08e-07	2.23e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—EP300—prostate cancer	2.07e-07	2.23e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—prostate cancer	2.05e-07	2.2e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—prostate cancer	2.03e-07	2.19e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—prostate cancer	2.03e-07	2.18e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—prostate cancer	2.03e-07	2.18e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.02e-07	2.17e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—prostate cancer	2e-07	2.16e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—prostate cancer	1.99e-07	2.14e-06	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—prostate cancer	1.98e-07	2.13e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—EP300—prostate cancer	1.95e-07	2.1e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—EP300—prostate cancer	1.93e-07	2.08e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.92e-07	2.06e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—INS—prostate cancer	1.91e-07	2.06e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CREBBP—prostate cancer	1.87e-07	2.01e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.78e-07	1.91e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.76e-07	1.89e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—prostate cancer	1.73e-07	1.86e-06	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—prostate cancer	1.7e-07	1.82e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—prostate cancer	1.68e-07	1.8e-06	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—prostate cancer	1.66e-07	1.79e-06	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—prostate cancer	1.66e-07	1.78e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—EP300—prostate cancer	1.65e-07	1.78e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.57e-07	1.69e-06	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—prostate cancer	1.57e-07	1.68e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.55e-07	1.66e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—prostate cancer	1.53e-07	1.65e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—prostate cancer	1.53e-07	1.65e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.44e-07	1.55e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—prostate cancer	1.44e-07	1.54e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.43e-07	1.54e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—prostate cancer	1.34e-07	1.44e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—prostate cancer	1.28e-07	1.38e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—EP300—prostate cancer	1.28e-07	1.37e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—prostate cancer	1.25e-07	1.34e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.22e-07	1.31e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—prostate cancer	1.18e-07	1.27e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—prostate cancer	1.17e-07	1.26e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—prostate cancer	9.98e-08	1.07e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.43e-08	1.01e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—prostate cancer	7.71e-08	8.29e-07	CbGpPWpGaD
